Page last updated: 2024-11-04

sumatriptan and Dilatation, Pathologic

sumatriptan has been researched along with Dilatation, Pathologic in 1 studies

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Dilatation, Pathologic: The condition of an anatomical structure's being dilated beyond normal dimensions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Friberg, L1
Olesen, J1
Iversen, HK1
Sperling, B1

Other Studies

1 other study available for sumatriptan and Dilatation, Pathologic

ArticleYear
Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan.
    Lancet (London, England), 1991, Jul-06, Volume: 338, Issue:8758

    Topics: Adult; Aged; Blood Flow Velocity; Cerebral Arteries; Cerebrovascular Circulation; Dilatation, Pathol

1991